title: Scaling from challenge experiments to the field: Quantifying the impact of vaccination on the transmission of bluetongue virus serotype 8.
abstract: Bluetongue (BT) is an economically important disease of ruminants caused by bluetongue virus (BTV) and transmitted by Culicoides biting midges. The most practical and effective way to protect susceptible animals against BTV is by vaccination. Data from challenge studies in calves and sheep conducted by Intervet International b.v., in particular, presence of viral RNA in the blood of challenged animals, were used to estimate vaccine efficacy. The results of the challenge studies for calves indicated that vaccination is likely to reduce the basic reproduction number (R(0)) for BTV in cattle to below one (i.e. prevent major outbreaks within a holding) and that this reduction is robust to uncertainty in the model parameters. Sensitivity analysis showed that the whether or not vaccination is predicted to reduce R(0) to below one depended on the following assumptions: (i) whether "doubtful" results from the challenge studies are treated as negative or positive; (ii) whether or not the probability of transmission from host to vector is reduced by vaccination; and (iii) whether the extrinsic incubation period follows a realistic gamma distribution or the more commonly used exponential distribution. For sheep, all but one of the vaccinated animals were protected and, consequently, vaccination will consistently reduce R(0) in sheep to below one. Using a stochastic spatial model for the spread of BTV in Great Britain (GB), vaccination was predicted to reduce both the incidence of disease and spatial spread in simulated BTV outbreaks in GB, in both reactive vaccination strategies and when an incursion occurred into a previously vaccinated population.
authors.affiliation: Institute for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Surrey GU24 0NF, UK. simon.gubbins@iah.ac.uk
authors.forename: S
authors.initials: S
authors.lastname: Gubbins
authors.forename: N A
authors.initials: NA
authors.lastname: Hartemink
authors.forename: A J
authors.initials: AJ
authors.lastname: Wilson
authors.forename: V
authors.initials: V
authors.lastname: Moulin
authors.forename: C A
authors.initials: CA
authors.lastname: Vonk Noordegraaf
authors.forename: M T W
authors.initials: MT
authors.lastname: van der Sluijs
authors.forename: A J
authors.initials: AJ
authors.lastname: de Smit
authors.forename: T
authors.initials: T
authors.lastname: Sumner
authors.forename: D
authors.initials: D
authors.lastname: Klinkenberg
mesh_terms: D000818:Animals; D050936:Basic Reproduction Number; D001819:Bluetongue / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D001820:Bluetongue virus / Q000145:classification / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D002519:Ceratopogonidae; D008962:Models, Theoretical; D012367:RNA, Viral / Q000097:blood; D012703:Serotyping; D012756:Sheep; D006113:United Kingdom; D014611:Vaccination / Q000662:veterinary*; D014765:Viral Vaccines / Q000008:administration & dosage*
chemical_list: D012367:RNA, Viral; D014765:Viral Vaccines